文献速递中医内科中药与中成药合理使用

柴芩清宁胶囊解热镇痛作用及机制的系统性再评价

Systematic reevaluation on the antipyretic, analgesic effects, and uncover the mechanisms of Chaiqin Qingning capsule, a traditional Chinese medicine, via establishing lipopolysaccharide - induced fever models, physical and chemical - stimuli pain models.
PubMed 文献 · J Ethnopharmacol · 2025-08-14

柴芩清宁胶囊(CQQNC)是用于缓解呼吸道感染所致发热与咽痛的中成药。本研究通过LPS诱导的大鼠发热模型与RAW264.7细胞模型、热板与醋酸扭体及福尔马林疼痛模型,系统再评价其解热镇痛作用及机制。结果显示CQQNC剂量依赖性地降低发热大鼠体温和多种发热介质,并提高痛阈值、减少疼痛行为,机制分别涉及抑制TLR4/MyD88/PI3K通路和调节NMDAR2B/CaMKIIa/NO/PKG通路。

要点

  • CQQNC可剂量依赖性降低LPS发热大鼠体温及血清、脑脊液、肺组织炎症介质。
  • CQQNC在热板、醋酸扭体和福尔马林模型中均显示镇痛效应。
  • 解热机制与抑制TLR4/MyD88/PI3K通路有关,镇痛机制与调节NMDAR2B/CaMKIIa/NO/PKG通路有关。

核心结论

  • 柴芩清宁胶囊具有显著解热、镇痛和抗炎作用,支持其用于呼吸道感染所致发热和疼痛症状。

研究设计与样本

  • 采用LPS诱导的大鼠发热模型和RAW264.7细胞发热模型进行体内外解热再评价。
  • 采用热板试验和醋酸扭体试验评估镇痛作用,并建立福尔马林诱导大鼠疼痛模型验证机制。
  • 大鼠经CQQNC治疗5天后腹腔注射LPS(100 μg/kg),每小时监测体温。

主要发现

  • CQQNC显著降低发热大鼠体温,并剂量依赖性降低血清、脑脊液、细胞上清和肺组织中IL-1β、IL-6、TNF-α、cAMP和PGE2水平。
  • CQQNC在热板和醋酸扭体试验中显著提高痛阈值,在福尔马林模型中减少舔咬足时间和足肿胀。
  • CQQNC显著降低血清和脊髓组织中SP、NO和cGMP水平。

关键数值与推荐

  • 解热机制涉及抑制TLR4/MyD88/PI3K通路,表现为降低LPS诱导的体内外模型中TLR4、MyD88和磷酸化PI3K蛋白表达。
  • 镇痛机制涉及下调福尔马林诱导大鼠脊髓组织中c-fos、NMDAR2B、CaMKIIa、NO和PKG蛋白表达,调节NMDAR2B/CaMKIIa/NO/PKG通路。

临床怎么用

  • 对于呼吸道感染所致发热和咽痛,可考虑使用柴芩清宁胶囊,其解热镇痛作用有基础研究证据支持。
  • 其解热作用可能与抑制TLR4/MyD88/PI3K通路减少发热介质生成有关,镇痛作用可能与调节NMDAR2B/CaMKIIa/NO/PKG通路有关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Chaiqin Qingning capsule (CQQNC), a traditional Chinese patent medicine, has been extensively used in alleviating fever and throat pain caused by respiratory tract infections, without obvious adverse reactions. However, there still lack of systematically basic reevaluation in its antipyretic, analgesic effects, and potential mechanisms unveiled. AIM OF THE STUDY: This studies aimed to systematically reevaluate the antipyretic and analgesic effects of CQQNC, and reveal its underlying mechanisms using LPS-induced fever models in vitro and in vivo, and physical and chemical-stimulated pain animal models, respectively. MATERIALS AND METHODS: Firstly, systematic reevaluation on the antipyretic effects of CQQNC was evaluated in vivo and in vitro using LPS-induced fever models in rats and RAW264.7 cells. Briefly, body temperature was monitored per hour after intraperitoneal injection of LPS (100 μg/kg) in rats after the treatment of CQQNC for 5 days. Fever-related mediators (IL-1β, TNF-α, cAMP and PGE2) in serum, cerebrospinal fluid (CSF), hypothalamus or lung tissues were measured using commercial enzyme-linked immunosorbent assay (ELISA) kits based on the operating instructions. Simultaneously, LPS-stimulated RAW264.7 cell fever model was constructed, and CQQNC effects on febrile factors were also detected by ELISA kits. Subsequently, the analgesic effects of CQQNC were systematically assessed using classic physical and chemical stimuli pain models of hot plate and acetic acid writhing tests. Furthermore, to validate the analgesic effects and unveil its mechanism, the formalin-induced pain rats model was established. The paw licking/biting time and foot swelling were chosen as evaluation metrics. Meanwhile, pain-related mediators (SP, NO, and cGMP) in serum or spinal cord tissue were quantified by ELISA kits. Protein expression of c-fos in spinal cord tissue was detected by immunohistochemistry. Finally, Western blotting was employed to un-reveal the antipyretic and analgesic mechanisms of CQQNC. RESULTS: Our results proved that CQQNC has good antipyretic and analgesic functions. Concretely, CQQNC significantly reduced the body temperature of fever rats, and markedly decreased the levels of febrile mediators (IL-1β, IL-6, TNF-α, cAMP and PGE2) in both serum, cerebrospinal fluid, cell supernatant, and lung tissue in a dose-dependent manner. Its antipyretic mechanism involved the inhibition of TLR4/MyD88/PI3K pathway, as evidenced by reducing protein expression of TLR4, MyD88, and phosphorylated PI3K in LPS-induced fever models in vitro and in vivo. Results on the analgesic reevaluation of CQQNC showed that CQQNC notably increased the pain thresholds in hot plate and acetic acid writhing tests, and reduced paw licking/biting time and swelling in formalin-induced rats. Meanwhile, ELISA tests demonstrated that CQQNC significantly diminished the levels of pain mediators including SP, NO, and cGMP in serum and spinal cord tissue. Protein expression results analysis identified that CQQNC could significantly downregulate the protein expressions of c-fos, NMDAR2B, CaMKIIa, NO, and PKG in spinal cord tissue of formalin-induced rats, indicating the analgesic mechanism of CQQNC was via the modulation of the NMDAR2B/CaMKIIa/NO/PKG pathway. CONCLUSION: CQQNC exhibits significant antipyretic, analgesic, and anti-inflammatory properties. The antipyretic effects and mechanism of CQQNC involve the regulation of TLR4/MyD88/PI3K pathway to inhibit the productions of febrile mediators including IL-1β, IL-6, TNF-α, cAMP and PGE2. CQQNC showed good analgesic effects in both physical and chemical stimuli. Its analgesic mechanism may be associated with the regulation of NMDAR2B/CaMKIIa/NO/PKG pathway. Collectively, this studies provide novel insights into CQQNC's antipyretic and analgesic mechanism of actions, and support its clinical application for treating fever and pain symptoms caused by respiratory tract infections.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Huang L, Gao H, Halihaman B, et al. Systematic reevaluation on the antipyretic, analgesic effects, and uncover the mechanisms of Chaiqin Qingning capsule, a traditional Chinese medicine, via establishing lipopolysaccharide - induced fever models, physical and chemical - stimuli pain models. J Ethnopharmacol. 2025. PMID: 40818520. doi:10.1016/j.jep.2025.120432

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。